Progress of immunocellular therapy in treatment of IBD
10.3969/j.issn.1000-484X.2024.06.035
- VernacularTitle:免疫细胞疗法在IBD治疗中的研究进展
- Author:
Jianwei ZHOU
1
;
Zhe ZHANG
;
Xia LIU
;
Yaxing SUN
;
Liang WANG
;
Baisui FENG
Author Information
1. 郑州大学第二附属医院消化内科,郑州 450014
- Keywords:
Inflammatory bowel disease;
Immunocellular therapy;
Regulatory T cell;
Dendritic cell
- From:
Chinese Journal of Immunology
2024;40(6):1324-1328
- CountryChina
- Language:Chinese
-
Abstract:
Inflammatory bowel disease(IBD)is a disease characterized by chronic,recurrent intestinal inflammation,includ-ing Crohn's disease(CD)and ulcerative colitis(UC).Etiology and pathogenesis of IBD are unknown,and the treatment is difficult.In recent years,immunocellular therapy represented by regulatory T(Treg)cell therapy and dendritic cell(DC)therapy has developed rapidly in the field of immune-related disease treatment,and some progress has also been made in the treatment of IBD.This review will introduce application and progression of Treg cell therapy and DC therapy in IBD treatment.
